Announcements Trials
Browse Landscape

Phase

Phase 2 96Phase 1 63Phase 1/2 31Phase NA 19Phase 3 17Phase EARLY_PHASE1 3Phase 2/3 3Phase 4 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 46Melanoma 27Skin Neoplasms 14Carcinoma, Basal Cell 9Lymphoma, T-Cell, Cutaneous 8Neoplasm Metastasis 5Mycosis Fungoides 5Lung Neoplasms 5Keratosis 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma 3Breast Neoplasms 3Uveal Melanoma 2Skin Diseases 2Sezary Syndrome 2Prostatic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Squamous Cell Carcinoma of Head and Neck 1Skin Substitutes 1Seroma 1Renal Transplant Patients at High-risk for Skin Cancer 1Psoriasis 1Pituitary Neoplasms 1Pituitary ACTH Hypersecretion 1

Interventions

Triamcinolone Acetonide 1Ranibizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Uveal Melanoma × Dermatologic × Clear all
NCT02379000 2017-02-08

TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy

Charite University, Berlin, Germany

Phase 4 Unknown
50 enrolled
Dermatologic

Uveal Melanoma

NCT00540930 2007-10-08

Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy

Shields, Shields and Associates

Phase 4 Unknown
400 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡